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ABSTRACT: In vivo studies have shown cyclic bile salt (BS) outputs during fasting whereas higher 
amounts have been observed in fed states. This leads to fluctuations of intestinal BS concentrations 
([BS]) that can affect the rate and extent of absorption of lipophilic drugs in particular. However, most 
PBPK models use fixed values of [BS] in fasted and fed states albeit with different values in different 
regions of the GI tract. During fasting, there is a relationship between gallbladder volume (GBV) and 
the phase of the Interdigestive Migrating Motor Complex cycle (IMMCc), showing cyclic GBV changes 
with periodic filling and emptying. This relationship is also affected by the origin of the IMMCc (antral 
or duodenal). In fed states, meta-analysis indicated that GB residual volume (% of fasting maximum) 
was 46.4 ±27 %CV and 30.7 ±48 %CV for low- and high-fat meals respectively. The corresponding val-
ues for the duration of the emptying phase were for low fat meals 0.72h ±1%CV and for high fat meals 
1.17h ±37%CV. The model, the Advanced Dynamic Bile Salt Model (ADBSM), was built bottom-up 
and its parameters were not fitted against in vivo measurements of [BS]. It involved update of the dy-
namic luminal fluid volumes model based on meta-analysis of available imaging data. The ADBSM is 
incorporated into the Simcyp® (v18r2) PBPK simulator. The model predictivity was good (within 1.25 
fold error for 11/20 of the clinical studies) and was assessed against clinical studies of luminal [BS] that 
provide only the type of meal (i.e., low- or high-fat), the timing of the meal and/or water intake events, 
and the number and age range of the study participants. The model is also an important component of 
models capturing enterohepatic recirculation of drug and metabolite. Further work is required to validate 
the current model and compare to simpler models with respect to drug absorption, especially of the lipo-
philic compounds.  
 






Along with other parameters, such as stability, permeability and first-pass metabolism, solubility in lu-
minal fluids is considered to be a key factor for the prediction of oral drug bioavailability. Bile salts (BS) 
play a crucial role in the solubilisation and absorption of lipophilic and poorly soluble compounds.25-27 
Several studies have been conducted in the past to characterize fasting and fed duodenal, jejunal and 
colonic aspirates in healthy2, 27-31 and non-healthy (e.g., with ulcerative colitis)32 subjects. These studies 
have been used to design simulated biorelevant media (FaSSIF, FeSSIF) enabling in vivo prediction of 
drug solubility.33 Similarly, this information has been implemented in in-silico platforms; e.g., SimCYP, 
as a part of the Advanced Dissolution Absorption and Metabolism (ADAM) model34, GastroPlus and GI-
SIM.35 However, BS concentrations ([BS]) used in in vitro dissolution experiments and in PBPK model-
ling are fixed and represent a snapshot of the dynamically changing in vivo environment. Furthermore, 
the in vivo information on [BS] integrated into in vitro and in- silico models, doesn’t currently take into 
account biliary motility when aspirating duodenal and/or jejunal fluids. For instance, [BS] varies signifi-
cantly within the GI tract due to a number of factors such as cyclic motility patterns of the gallbladder 
(GB) linked to the phase of the IMMCc,13, 36, 37 dynamic intestinal water volumes changes38, 39 and post-
prandial strong GB contractions emptying a significant amount of BS.5, 19 Furthermore, several studies 
have shown that in the fed state, the GB ejects 30 – 70% of its content within 20 - 30 mins, depending on 
meal composition.4, 8, 39, 40 Effort has been put into the development of mechanistic models incorporating 
biliary motility with the main focus on the GB. Guiastrennec et al.,41 developed a mechanistic model of 
GB emptying  in response to calorie intake with the intention to use it for predicting postprandial changes 
in drug absorption. However, the Guiastrennec et al.,41 mechanistic model describes GB motility only in 
the fed state and is based on a single in vivo study.40 A different approach for mechanistically modelling 
GB motility is to link it to the secondary peaks appearing in the plasma concentration profile of drugs 
undergoing enterohepatic circulation (EHC). Abbiati and Manca42 developed a PBPK model which links 
the GB emptying period with the onset time of secondary peaks in plasma concentration of sorafenib. 
However, this approach is essentially fitting the GB motility to reproduce the observed secondary peaks 
and does not take into account the different factors affecting/controlling GB motility. In other words, it 
may not be appropriate to link GB motility exclusively to the onset time of a secondary peak in the drug’s 
plasma concentration profile; secondary peaks have appeared in cholecystectomized patients as well as in 
rats which do not have a gallbladder. The same approach has been taken by Jain et al.43 A more physio-
logically relevant mechanistic model of EHC has been developed by Lehr et al44 with the introduction of 
a clock time function as a control element of a trigonometric GB release function mimicking an ultradian 
rhythm. However, interindividual variability was applied only to the clearance and the distribution volume 
of the targeted drug (tesofensine). MRI and ultrasound measurements of fasting GB volume indicate high 
inter-subject variability.19 Furthermore, the GB volume changes linked to the IMMC are too complex22 to 
be described by a simple sine function.44 Another limitation of the Lehr et al44 approach is that the ultra-
dian rhythm of the GB is linked to (i.e., starts at) the time of dose administration. However, dose can be 
administered randomly with respect to filling-emptying cycles of the GB which means, for example, that 
the GB won’t necessarily enter an emptying phase due to drug administration. So, in order to be able to 
adequately predict the duodenal [BS] in fasted and fed states, GB motility ideally should be directly mod-
elled based on the physiological parameters affecting it. 
Thus, the present study aims to develop a more generalized mechanistic model of biliary system motility 
with the main focus on the GB, reflecting current knowledge obtained by a systematic literature review 
and meta-analysis. Thus, specific relationships between GB motility, residual volumes, bile secretion rates 
and gut motility in the fasting and fed states, are defined in order to build the mechanistic model. A general 
aim of the proposed mechanistic model is for it to be as flexible as possible in order to be easily coupled 
to EHC of different drugs and their primary and secondary metabolites. Furthermore, the proposed mech-
anistic model is coupled with the previously developed and recently updated Dynamic Fluid Volume 
 
model, as part of ADAM platform in SimCYP, to account the time-dependent intestinal [BS]. It is essential 
to use as accurate as possible luminal fluid volumes in order to simulate accurate [BS]. 
 
METHODS 
Prior to model development, a systematic literature review and meta-analysis of the selected articles was 
conducted using PubMed and Scopus search engines. Reviews focused on th biliary system37, 45-47 were 
screened first to gain a general idea about biliary motility and the factors affecting its functionality in 
fasting and fed conditions. Useful articles were manually extracted from those reviews and screened for 
eligibility. Then, the literature review focused first on GB motility and its relationship to gastroduodenal 
motility in the fasted state and thereafter to postprandial periods. The terms, “gallbladder”, “gallbladder 
emptying”, “gallbladder volume” and “Interdigestive Migrating Motor Complex” (IMMC) were used for 
the fasting state whereas “postprandial gallbladder motility” and “postprandial gallbladder volume” were 
used for the fed state. Search results were restricted to full text articles written in the English language, 
including healthy human subjects, of adult Caucasians. Additional articles were found through the manual 
search of included studies’ references. Apart from the general criteria, the analytical methods used to 
monitor gallbladder motility in fasting and fed were critically evaluated and used as an inclusion or ex-




1. Studies including healthy Caucasian subjects older than 18 years. 
2. Studies using a physiological stimulus (i.e. meal) for postprandial gallbladder motility examina-
tion and giving details about the kcal and composition of the testing meal. 
3. Studies using real-time ultrasonography and/or continuous scintigraphy as well as other validated 
imaging techniques like MRI. 
 
Exclusion criteria: 
1. Studies with pediatric age subject or animals. 
2. Studies performing scintigraphy with single i.v. injection of radiotracer. 
3. Studies where hormones like Cholecystokinin (CCK) and motilin were used to stimulate 
gallbladder and gastroduodenal motility. 
 
In addition, literature review and meta-analyses were conducted for hepatic biliary secretions in fasted 
and fed conditions where, especially for the fed, only studies using physiological stimulus (i.e., a meal) 
were included. Furthermore, perfusion studies which provide data for the absorption of bile salts in dif-
ferent regions of the GI tract were also included. 
Furthermore, papers providing individual profiles rather than only average profiles were mainly used to 
support the development of the model. The corresponding authors were contacted to provide the raw data 
from clinical studies under the new GDPR rules. 
 
RESULTS 
An initial screening showed 4,129 studies which potentially could be included (Fig. 1). After reviewing 
the title and abstract, 689 studies were selected for further analysis. Then 644 studies were excluded ac-
cording to exclusion criteria as described in the methodology. Finally, the remaining 26 articles were 
subdivided into three groups, fasting, fed and human BS perfusion studies (3 articles). Fasting and fed 
 
groups were further divided into two subgroups: fasted-GB (7 articles), fasted-BS (3 articles), fed-GB (10 
articles) and fed-BS (3 articles). 
 
 













Fig. 1. Flow chart of the strategy used to select relevant studies. The literature search was done according 
to the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA); 
Gallbladder (GB), Bile Salts (BS), Absorption (BS) 
 
Fasting 
Various studies have shown strong correlation between the cyclic GB motility (i.e., repeating emptying 
and filling phases) and the IMMC 13, 22. Unlike the filling phase, the residual GB volume and the duration 
of the emptying phase depend on the origin of the IMMCc (gastric or duodenal). In particular, GB filling 
starts at phase I of the IMMCc with the GB reaching its maximum volume at 30% of the IMMCc cycle13, 
22. Thereafter emptying takes place which ends at 90% of the IMMCc, where phase III starts is of antral 
origin, or at 60% when phase III is of duodenal origin.13 Thereafter, a steady period, i.e. no further decrease 
or significant increase in the GB volume, takes place. Converting the GB fraction vs IMMC fraction 
relationship to actual GB volume (mL) and IMMC duration time (h), individual fasting GB volume 
change profiles can be generated with both intra- and inter-subject variability. This means that each Fill-
ing-Emptying (F-E) cycle is not the same within an individual’s GBV profile. The generation of an indi-
vidual 24 h GB profile is performed as follows: 
1) Individual maximum GB volume (mGBv): in order to calculate GBV fraction at each IMMC time 
point, the mGBv per individual is needed. The mGBv (mL), which is taken to represent the maxi-
mum anatomical GB volume, is considered the maximum volume reported in the studies used in the 
meta-analysis. Normally fasting GB volume is measured 5, 10, 15 min or more before meal. For 
those studies which provide only the mean value of those measurements per individual is used as 
“the anatomical GB volume”. However, for those studies reporting all the measurements, only the 
maximum value is selected. To generate an individual mGBv, random sampling is performed from 
a normal distribution with mean=18.8 mL, %CV= 53, and range= 4.0 - 93.0 mL (Table 1). 
  
2) Number and duration of IMMC events per individual: now the %IMMC time points need to be 
converted to actual time (h). First it should be pointed out that the number (N) of F-E cycles and the 
duration of each Nth cycle should be linked to the number of IMMC events observed in an individual 
Total number of records (4,129) 
After screening title-abstract (687) 
Papers fulfil inclusive criteria (43) 
Fasted 
GB (16) BS (3) 
Papers included in meta-analysis (26) 
Fed 
GB (17) BS (4) Abs of BS (3) 
Fasted 
GB (10)13-22 BS (3)1-3 
Fed 
GB (9)4-12 BS (2)1, 2 Abs of BS (2)23, 24  
 
within a 24h  period time as well as to the duration of each IMMC. Furthermore, the duration of each 
IMMC depends on the origin (i.e. antrum or duodenum). Although, IMMC can start from other ori-
gins, i.e. esophagus, jejunum49, however, limited info was found with regards to fasting GB volume 
vs IMMC profile, in particular in jejunum.50 Hence, the meta-analysis was focused on IMMC events 
started from antrum and duodenum. So, the percentage (i.e. the probability) of the IMMC events 
started from antrum was obtained by dividing the number of IMMC events commencing for example 
in the antrum with the total number of IMMC events commencing in both regions, antrum and duo-
denum. Thus, the probability of the IMMC starting from the antrum is 60% and 40% from duode-
num. Then, a random number between 0-1 is generated from a uniformly distributed random num-
bers. If this number is <0.6, then the first IMMC event is assigned to antrum and hence the duration 
(h) of this IMMC event is randomly generated from normal distributed data with mean=2.6, %CV= 
30.2, and range=0.9 - 4.3 (Table 1). Otherwise the IMMC is assigned to duodenum with mean=1.3, 
%CV=60.3 and range=0.5 – 3.4. The same procedure was repeated for the next IMMC and until the 
cumulative sum of the duration of the IMMC events is in total ≤24 h for every individual. 
3) Obtaining filling and emptying rate constants for each F-E cycle of each individual: knowing the 
individual mGBv and the duration of each IMMC, the corresponding GB volumes at 60 and 90% of 
each IMMC can be obtained. In particular, a random %GBV value is generated from normal distrib-
uted data with mean= 74.0, %CV= 10, and range=70 – 100, in case where the IMMC starts from 
antrum, and mean= 80.7, %CV= 17, and range= 70 – 100, if IMMC starts from duodenum. This 






Table 1.  Values of the parameters used in the model to generate individual gallbladder volume changes profile 
as well as the active and passive absorption components of BA in GI tract segments.
Parameter name PopRep* %CV Min Max 
IMMC Cycle (Antral Origin) (h) 2.6 30.2 0.9 4.3 
IMMC Cycle (Duodenal Origin) (h) 1.3 60.3 0.5 3.4 
Probability of IMMC Cycle Originating in the Antrum (%) 60 NA 0 100 
Probability of IMMC Cycle Originating in the Duodenum (%) 40 NA 0 100 
Maximal Gallbladder Volume (mL) 18.8 53 4.0 93.0 
Fasted Gallbladder Residual Volume (%)- IMMC of Antral Origin  74.0 10 70.0 100 
Fasted Gallbladder Residual Volume  (%)- IMMC of Duodenal Origin 80.7 17 70.0 100 
Gallbladder Residual Volume (%) Fed, High-Fat 30.67 48 3.70 99.50 
Gallbladder Residual Volume (%) Fed, Low-Fat 46.36 27 27.0 79.2 
Duration of Gallbladder Emptying Period (h), High-Fat 1.17 37 0.33 2.08 
Duration of Gallbladder Emptying Period (h), Low-Fat 0.72 1.18 0.717 0.733 
 
Pappcoef for Jejunum I-II (mmol/h/mM)a 0.42 14 0 0.54 
Jmax for Ileum I-IV (mmol/h)b 2.48 20 0 3.49 
 Km for Ileum I-IV (mmol)c 0.6 33 0 1 
 Pappcoef for Colon (mmol/h/mM)a 0.0565 30 0 1 
fBSabs Jejunum I-IId 0.15 NA 0 1 
fBSabs Ileum I-IId 0 NA 0 1 
fBSabs Ileum III-IVd 0.05 NA 0 1 
fBSabs Colond 1 NA 0 1 
BS Weighted Avg. MWt. 400 - 100 1000 
Fasted-HBS massrate (mmol/h)e  0.19 69 0.12 0.28 
Fed-(HBSmassrate) (mmol/h)e  1.33 45 1.33 1.44 
% of Hepatic Bile Entering Gallbladder 70.3 32.1 0 100 
a Pappcoef= Apparent permeability coefficient (mmol/h/mM); bJmax= Maximum Rate of Bile Absorp-
tion (mmol/h); cKm= Michaelis-Menten constant (mmol); dfBSabs= Bile salt fraction available for absorp-
tion; *PopRep: Population Representative values; eTotal Hepatic Bile Salts Mass Rate (mmol/h)
 
according to the origin. In addition, this first generated %GBV value is used as the initial condition (t=0) 
for generating the individual 24 h fasting GB volume changes profiles. As mentioned above the mGBv is 
normally observed at 30% of the IMMCc. Thus, it is assumed that the GB volume at 30% of each IMMCc, 
 
always corresponds to the mGBv. This is in accordance with the observed data where the GB’s filling 
phase continues, unless meal is given, until the mGBv has been reached and thereafter a new emptying 
phase will occur.22, 51  It is also assumed that the 
filling phase takes place is zero order (IMMCc= 0 
– 30%), whereas the emptying phase under first 
order kinetics52 followed by a constant volume. 
The filling (Eqs. 1-2) and emptying (Eqs. 3-4) rate 
constants used to generate the individualized 24 h 





















(h-1)   (4) 
Where the letters ‘a’ and ‘d’ denote the origin of 
the IMMCc (‘a’=antral and ‘d’=duodenal) 
whereas DurIMMC denotes the actual duration of 
the Nth IMMC (h). After obtaining the F-E con-
stants for 1st, 2nd, …, Nth IMMC assigned to 1st, 
2nd, …, ith individual, the following equations 
were used for the filling (Eq. 5), emptying (Eq. 6) 
and steady period (Eq. 7) to obtain all the data 




= 𝑘𝑘𝑓𝑓𝑓𝑓𝑓𝑓𝑎𝑎𝑖𝑖−𝑁𝑁,   
𝑑𝑑𝑚𝑚𝑚𝑚𝐺𝐺
𝑑𝑑𝑑𝑑




= −𝑘𝑘𝑒𝑒𝑚𝑚𝑎𝑎𝑖𝑖−𝑁𝑁 ∗ 𝐺𝐺𝐺𝐺𝐺𝐺 , 
𝑑𝑑𝑚𝑚𝑚𝑚𝐺𝐺
𝑑𝑑𝑑𝑑




= 0                                                     (7) 
 
Fig. 2 shows how the observed relationship between %GBV and %IMMC is converted to individual 





of each IMMC per individual and %GBV at t=0 (only once per individual), 60% or 90% depending on 
the origin of each IMMC. Fig. 2C shows clearly the difference between E-F cycles which associated with 
IMMCc of duodenal and antral origins, in terms of decrement of GBV and duration of emptying phase. 
Fig. 2. Generation of 24h individual fasting GBV profiles. A) Relationship between %GBV and 
%IMMC with respect to the origin of the IMMC.  The horizontal solid bars indicate the different GB F-
E phases with respect to the IMMC for both origins, D:duodenal and A:antralm (modified from Stolk et 
al 199313); B) An example showing how a %GBV vs. %IMMC profile is created for one IMMC cycle 
from in vivo data (A) after generating random %GBV numbers sampled within the specific range of the 
normal distribution curves at 60% of IMMC for those IMMCs originating in the duodenum and at 90% 
of IMMC for those IMMCs of antral origin; at t=0, random sampling performed only once per individual; 
C) An example of a 24h fasting GBV profile of a representative (average) individual with mGBV= 18.8 
(mL), 12 IMMC events where 7 starting from antrum and 5 from duodenum with a sequence as followed: 
A A D A A D D D A A D A 
Fed 
Strong contractions of the GB occur upon stimuli such as after meal ingestion. Depending on the strength 
of the stimulus, e.g. fat content of the meal, the residual GBV and the duration of the emptying phase vary 
significantly. Clinical studies passing the inclusion criteria were split to two groups based on the %fat 
caloric content contributing to the total kcal of the meal. Thus, a high-fat meal is defined when the %kcal 
coming from fat is ≥40%. Meta-analysis showed that the duration of the GB emptying phase is for 0.72 
±30 (%CV) h (range: 0.5 – 0.73 h) and 1.17 ±37 (%CV) h (range: 0.33 – 2.08 h) for low- and high - fat 
meals respectively (p<0.05). After the emptying period, the GB enters the refilling phase, treated as zero 
order as indicated previously, until reaching the maximum (‘anatomical’) volume,5 unless interrupted by 
further food intake.53 Based on our knowledge and the available data in the public domain, there are not 
enough prolonged recordings of the GB motility to show if the GB enters the fasting F-E cycling profile 
exactly after the postprandial refilling period. Thus, it’s assumed that after GB reaches the maximum 
volume, a new fasting F-E cycling pattern is followed which continuous until the next meal. Furthermore, 
the common practice to investigate GBV changes and duodenal [BS] under multiple meals is to administer 
food every 4, 5 and/or 6 h.1, 53-55 However, it was not where possible to find information indicating how 
the GB behaves with shorter time intervals between the meals (e.g. every 1, 2, 3 h etc.). Nevertheless, 1 
or 2 h time interval between meals might be too short reflecting a situation where the GB would be phys-
iologically inactive due to continuous feeding.54 Thus, the proposed model allow the GB to enter a fed 
state only if the next meal is 4 h after the previous one, otherwise the GB’s refilling phase continues until 
mGBv has been reached.  
Generation of the individual fed GBV profile is performed as follows: A meal can be given at random 
time point during an individual IMMCc and thus at a random point dur-ing the GB cyclic fasting profile; 
the meal, of course, interrupts the fasting profile. Thus, the fasting GBV (taken from the pre-generated 
fasted GBV profile) at the time of interruption (𝑡𝑡1) is 
used as the starting point for the emptying phase of 
the GB in the fed state (𝐺𝐺𝐺𝐺𝐺𝐺@𝑑𝑑1). Fed state GB emp-














𝑡𝑡2 = 𝑡𝑡1 +  𝑡𝑡𝑒𝑒𝑚𝑚 (ℎ)   
 
𝐺𝐺𝐺𝐺𝐺𝐺@𝑑𝑑2 = (𝐺𝐺𝐺𝐺𝐺𝐺@𝑑𝑑1 ∗ 𝑅𝑅𝑅𝑅𝑅𝑅𝐺𝐺𝑅𝑅𝑅𝑅%)/100   (mL) 
 
ResVol%= %Residual Volume of GBV@t1 which is randomly generated from normally distributed data 
with mean=30.67, %CV=48, and range=3.7 – 99.5 for high-fat meals or, for low fat meals, mean=40.36, 
%CV=27, and range=27 – 79.2. 
 
To generate individual fed GBV profiles, a transition from the emptying to refilling phase is needed. 
Meta-analysis showed that there is a linear correlation (R2=0.6, SF12) between the emptying rate constant 
𝑘𝑘𝑚𝑚𝑚𝑚𝑒𝑒𝑚𝑚𝑓𝑓𝑒𝑒𝑑𝑑 (h-1) (Eq. 9) and the refilling rate 𝑐𝑐𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 (mL/h), regardless of the fat content of the meal. Linear 
regression of the data gave Eq. 10 which was used in Eq. 11 to obtain the GB refilling profile. Thus, after 
obtaining 𝑘𝑘𝑚𝑚𝑚𝑚𝑒𝑒𝑚𝑚𝑓𝑓𝑒𝑒𝑑𝑑, Eq. 10 is used to calculate 𝑐𝑐𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓. Then Eq. 8 (t1 ≤ t < t2) and Eq. 11 (GBV@t2-i ≤ 
GBV < mGBv, i= lf or hf for a low fat or high fat meal respectively) are used to generate the fed GBV 
profile. 
 
𝑐𝑐𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 = 4.7363 ∗ 𝑘𝑘𝑚𝑚𝑚𝑚𝑒𝑒𝑚𝑚𝑓𝑓𝑒𝑒𝑑𝑑  (mL/h)        (10) 
 
 
     𝑑𝑑𝑚𝑚𝑚𝑚𝐺𝐺𝑓𝑓𝑖𝑖𝑓𝑓𝑓𝑓𝑖𝑖𝑓𝑓𝑓𝑓
𝑑𝑑𝑑𝑑
= 𝑐𝑐𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓                                           (11) 
 
Fig. 3 shows an example of a fasting-fed-fasting GBV profile for low- and high-fat meals. The GBV 
fasting profile prior to the meal corresponds to the fasting GBV profile as showed in Fig. 2C. After the 
end of refilling phase the GB enters the fasting profile which is re-generated as described in the fasted 
section for the remaining time period. This example illustrates the effect of a high-fat meal compared to 
a low-fat meal where normally a higher fraction of the stored bile is ejected from the GB into the duode-
num and the duration of the refilling phase is longer; ~3 h compared to ~1.5 h for a low-fat meal.  
 
Fig. 3. Example of fasting – fed – fasting transitions; a scenario where meal is given at a random time 
point of the 24 h GB volume profile; GBV@t2-lf: residual GBV after low-fat (lf) meal ingestion; 
GBV@t2-hf: residual GBV after high-fat (hf) meal ingestion; t1: random time-point of meal administra-
tion; t2-lf: time point at which the emptying phase ends after low-fat meal; t2-hf: time point at which 
emptying phase ends after high-fat meal. 
 
Bile Salt Disposition within GI Luminal segments 
Knowing the GBV profile, either fasting and/or fasting-fed-fasting, the fluctuating duodenal, jejunal, 
ileal and colonic bile salts –times concentrations profiles- (mM) can be obtained. However, it is also 
important to know hepatic bile salt secretions in the fasted and fed states, time-dependent water volume 
distribution and absorption kinetics within the different GI tract segments. The ADAM model in Simcyp 
simulator (v18r2) provides nine luminal segments (stomach, duodenum, jejunum 1-2, ileum 1-4 and co-
lon) with a dynamic water volume distribution in each segment, transit rate constants, dynamic (i.e., time 
varying) secretions (saliva, gastric and intestinal secretions such as from the Brunner’s glands)  as well as 
absorption rate constants for water. Furthermore, within this work, passive and active absorption of bile 
salts in the different ADAM GI tract segments was modelled based on absorption kinetics derived from 
 
human perfusion studies.23, 24 Based on the available data, passive absorption of BA predominates in je-
junum 1-2 and the colon whereas active absorption predominates in the ileal segments. For the passive 
component in jejunum 1-2, glycochenodeoxycholic acid (GCDC) was used as reference23 and chenodeox-
ycholate (CDCA) in colon24 whereas taurocholate (TA) was used as reference for active absorption in the 
ileal segments.23 However, TA, GCDC and CDCA are only a fraction of the total BA present in luminal 
fluids, hence the fraction available for passive absorption in the jejunum and colon as well as active ab-
sorption in ileum, should be assigned to the fraction of TA, GCDC and CDCA present in lumen aspirates.2, 
27 However, differences in the luminal bile salts compositions have been found between studies, which 
can be attributed population differences.2 In this work, the bile salt composition, as published by Riethorst 
et al (2016),2 was used as a case study based on which fractions of GCDC and TA were found to be 30% 
and 10%, respectively. Thus, for the passive component the fraction available was set to 0.15 for each 
jejunal segment. The active component was set to 0.05 for ileum 3 & 4 and zero for ileum 1 & 2, since 
the perfusions studies have been conducted mainly within the terminal ileum (i.e. within 30 cm of the 
ileocecal valve). The passive component was set to zero for all ileal segments, as active absorption takes 
place mainly within this region. 
Eqs 12 – 18 were used to obtain the time-dependent biliary secretions following the F-E phases of the 
pre-generated GBV profile: 
- Filling period of GB 
 
o Hepatic bile secretions (Hsr, mL/h) are back-calculated from the filling rate constant of the GB. 
This is based on the fact that the liver is the only source of bile flow during the closure of the sphincter 
of Oddi and relaxation of the GB muscle tissue. Thus the GB filling rate should reflect the hepatic se-
cretion rate, accounting also for the fraction of the bile entering the GB. 
𝐻𝐻𝑅𝑅𝐻𝐻(𝑡𝑡) = 𝑘𝑘𝑓𝑓𝑖𝑖𝑓𝑓
𝑓𝑓𝐷𝐷𝑏𝑏𝑖𝑖𝑓𝑓𝑒𝑒 𝑒𝑒𝑓𝑓𝑡𝑡𝑒𝑒𝑒𝑒 𝐺𝐺𝐺𝐺
                                              (12) 
where 𝑘𝑘𝑓𝑓𝑓𝑓𝑓𝑓 is derived from Eqs 1 and 2 and 𝑓𝑓𝐻𝐻𝑏𝑏𝑓𝑓𝑓𝑓𝑒𝑒 𝑒𝑒𝑓𝑓𝑑𝑑𝑒𝑒𝐷𝐷 𝑚𝑚𝑚𝑚 is the % of Hepatic Bile Entering Gallbladder 
(Table 1).  
o Bile flow rate to duodenum (BfD) mL/h:  
 
𝐺𝐺𝑓𝑓𝐵𝐵 (𝑡𝑡) = 𝐻𝐻𝑅𝑅𝐻𝐻(𝑡𝑡) ∗ (1 − 𝑓𝑓𝐻𝐻𝑏𝑏𝑓𝑓𝑓𝑓𝑒𝑒 𝑒𝑒𝑓𝑓𝑑𝑑𝑒𝑒𝐷𝐷 𝑚𝑚𝑚𝑚)             (13) 
 
o Rate of bile salt entering the duodenum (BSenDuo): 
 
𝐺𝐺𝐵𝐵𝑅𝑅𝐵𝐵𝐵𝐵𝐵𝐵𝑅𝑅 = 𝐻𝐻𝐺𝐺𝐵𝐵𝑚𝑚𝑎𝑎𝑚𝑚𝑚𝑚𝐷𝐷𝑎𝑎𝑑𝑑𝑒𝑒−𝑐𝑐 ∗ (1 − 𝑓𝑓𝐻𝐻𝑏𝑏𝑓𝑓𝑓𝑓𝑒𝑒 𝑒𝑒𝑓𝑓𝑑𝑑𝑒𝑒𝐷𝐷 𝑚𝑚𝑚𝑚)       (14) 
where 𝐻𝐻𝐺𝐺𝐵𝐵𝑚𝑚𝑎𝑎𝑚𝑚𝑚𝑚𝐷𝐷𝑎𝑎𝑑𝑑𝑒𝑒 is the hepatic bile salt mass rate, mmol/h (Table 1) and c = ‘fasted’ or ‘fed’. 
- Emptying period of GB 
 
o Hsr, according to Eq. 12 
 
o BfD 
𝐺𝐺𝑓𝑓𝐵𝐵(𝑡𝑡) = 𝐻𝐻𝑅𝑅𝐻𝐻 + 𝑘𝑘 ∗ 𝐺𝐺𝐺𝐺𝐺𝐺(𝑡𝑡)                                          (15) 
 
where k is the emptying rate constant (h-1) in fasted or fed state and switches from one state to another 
according to the GBV profile. 
o BSenDuo 
 
𝐺𝐺𝐵𝐵𝑅𝑅𝐵𝐵𝐵𝐵𝐵𝐵𝑅𝑅 (𝑡𝑡) = 𝐻𝐻𝐺𝐺𝐵𝐵𝑚𝑚𝑎𝑎𝑚𝑚𝑚𝑚𝐷𝐷𝑎𝑎𝑑𝑑𝑒𝑒−𝑐𝑐 + 𝑘𝑘 ∗ 𝐺𝐺𝐵𝐵𝐵𝐵𝐵𝐵𝐺𝐺𝐺𝐺(𝑡𝑡)         (16)  
where HBSmassrate and k have the same function as described in Eqs. 14 and 15, respectively. 
- Steady period of GB 
This period is only applied during the fasted state. 
 
o Hsr, according to Eq. 12 
 
o BfD 
𝐺𝐺𝑓𝑓𝐵𝐵(𝑡𝑡) = 𝐻𝐻𝑅𝑅𝐻𝐻                                                                (17)                                         
o BSenDuo 
𝐺𝐺𝐵𝐵𝑅𝑅𝐵𝐵𝐵𝐵𝐵𝐵𝑅𝑅(𝑡𝑡) = 𝐻𝐻𝐺𝐺𝐵𝐵𝑚𝑚𝑎𝑎𝑚𝑚𝑚𝑚𝐷𝐷𝑎𝑎𝑑𝑑𝑒𝑒𝑐𝑐                                         (18) 
Eqs. 19 – 21 were used to obtain time-variant luminal bile salt concentrations within the ADAM GI tract 











= 𝑘𝑘𝑡𝑡𝑓𝑓−1 ∗ 𝐺𝐺𝐵𝐵𝐵𝐵𝑓𝑓−1 − 𝑘𝑘𝑡𝑡𝑓𝑓 ∗ 𝐺𝐺𝐵𝐵𝐵𝐵𝑓𝑓 − 𝐾𝐾𝐾𝐾𝐾𝐾𝑅𝑅𝑓𝑓                                                                                      
     (20)       
 
𝐾𝐾𝐾𝐾𝐾𝐾𝑅𝑅𝑓𝑓 = 𝑃𝑃𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐𝑑𝑑𝑒𝑒𝑓𝑓𝑖𝑖 ∗ �𝐺𝐺𝐵𝐵𝐵𝐵𝑅𝑅𝐵𝐵𝑐𝑐(𝑡𝑡)𝑓𝑓 − 𝐺𝐺𝐵𝐵𝐵𝐵𝑅𝑅𝐵𝐵𝑐𝑐𝑏𝑏𝑎𝑎𝑚𝑚𝑒𝑒𝑓𝑓𝑓𝑓𝑓𝑓𝑒𝑒_𝑓𝑓� ∗ 𝑓𝑓𝑚𝑚𝑑𝑑𝑎𝑎𝑏𝑏𝑚𝑚𝑖𝑖−𝑃𝑃𝑎𝑎𝑃𝑃𝑃𝑃𝑖𝑖𝑃𝑃𝑒𝑒 + �
𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐(𝑑𝑑)𝑖𝑖
𝐾𝐾𝑒𝑒𝑖𝑖+𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐(𝑑𝑑)𝑖𝑖
� ∗ 𝐽𝐽𝑚𝑚𝑎𝑎𝑚𝑚𝑖𝑖 ∗
�𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐(𝑑𝑑)𝑖𝑖−𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐𝑏𝑏𝑎𝑎𝑃𝑃𝑒𝑒𝑓𝑓𝑖𝑖𝑓𝑓𝑒𝑒_𝑖𝑖
𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐𝑏𝑏𝑎𝑎𝑃𝑃𝑒𝑒𝑓𝑓𝑖𝑖𝑓𝑓𝑒𝑒_𝑖𝑖
� ∗ 𝑓𝑓𝑚𝑚𝑑𝑑𝑎𝑎𝑏𝑏𝑚𝑚𝑖𝑖−𝐴𝐴𝑐𝑐𝑡𝑡𝑖𝑖𝑃𝑃𝑒𝑒          (21) 
 
where i indexes the duodenum, jejunum 1… colon, BSm is the bile salt mass (mmol) in each segment, 
KAbs is the absorption rate constant of bile salts. 𝑓𝑓𝑚𝑚𝑑𝑑𝑎𝑎𝑏𝑏𝑚𝑚𝑖𝑖−𝑃𝑃𝑎𝑎𝑃𝑃𝑃𝑃𝑖𝑖𝑃𝑃𝑒𝑒  and 𝑓𝑓𝑚𝑚𝑑𝑑𝑎𝑎𝑏𝑏𝑚𝑚𝑖𝑖−𝐴𝐴𝑐𝑐𝑡𝑡𝑖𝑖𝑃𝑃𝑒𝑒  is the fraction of bile 
salts available for absorption for the active and passive component, respectively. 𝐺𝐺𝐵𝐵𝐵𝐵𝑅𝑅𝐵𝐵𝑐𝑐𝑏𝑏𝑎𝑎𝑚𝑚𝑒𝑒𝑓𝑓𝑓𝑓𝑓𝑓𝑒𝑒 is the 
[BS] baseline (i.e. steady state) in all ADAM segments based on prior meta-analysis. BSConc is the time-
dependent [BS] (mM). kt is the transit rate constant (h-1) derived from in-house meta-analysis of water 
volume distributions and transit in GI tract of healthy volunteers based on MRI and scintigraphy in vivo 
studies. Hence, the transit term, kt (h-1), “links” bile salt concentration from one segment to the other one. 
Pappcoef is the apparent permeability coefficient (mmol/h/mM), Jmax is the maximum rate of bile acid 
 
uptake (mmol/h) and Km is Michaelis-Menten constant (mmol). The values of Pappcoef, Jmax and Km are 
shown in Table 1. 
Eq. 21 shows that the passive and active absorption component is available for all ADAM segments but 
since, for example the passive component is considered to be zero in the ileum segment the first term of 
KAbs will be zero and hence only the second (i.e., active uptake) will contribute to the total [BS] in ileum. 
However, this gives flexibility to apply both or only one absorption component according to new findings 
or data available for bile salt absorption in GI tract. The terms �𝐺𝐺𝐵𝐵𝐵𝐵𝑅𝑅𝐵𝐵𝑐𝑐(𝑡𝑡)𝑓𝑓 − 𝐺𝐺𝐵𝐵𝐵𝐵𝑅𝑅𝐵𝐵𝑐𝑐𝑏𝑏𝑎𝑎𝑚𝑚𝑒𝑒𝑓𝑓𝑓𝑓𝑓𝑓𝑒𝑒_𝑓𝑓� and 
�𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐(𝑑𝑑)𝑖𝑖−𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐𝑏𝑏𝑎𝑎𝑃𝑃𝑒𝑒𝑓𝑓𝑖𝑖𝑓𝑓𝑒𝑒_𝑖𝑖
𝑚𝑚𝑑𝑑𝐷𝐷𝑑𝑑𝑓𝑓𝑐𝑐𝑏𝑏𝑎𝑎𝑃𝑃𝑒𝑒𝑓𝑓𝑖𝑖𝑓𝑓𝑒𝑒_𝑖𝑖
� (Eq. 21), prevent the [BS] to drop below BSConcbaseline. In most subjects 
BSConcbaseline> critical micelle concentration (CMC) of bile salts in the fated as well as the fed state. 




∗ 1000 (𝐵𝐵𝑚𝑚)   (22) 
where Vi(t) is the time-dependent fluid volume in the fasted or fed state in the ith ADAM GI tract segment 
(as discussed below, first-order transit rate constants are used). 
 
DISCUSSION 
After constructing all the equations describing the time-variant EHC of bile salts coupled to time-de-
pendent luminal fluid volumes, simulated luminal [BS] were obtained and compared to the observed data. 
The ADBSM was tested for its predictiveness with informing Simcyp® (v18r2) simulator only with the 
type of meal (i.e. low- or high-fat), the time of the meal intake and/or water intake events (using the Food 
Staggering Custom Dosing tool), the number, gender and age- range of the participants in each study. 
Thus, the ADBSM was not adjusted, optimized or tested against a single study. Moreover, it should be 
pointed out that none of the clinical studies selected for the performance verification (PV) provided in-
formation about GB volumes, transit rates, IMMC events and their duration, fluid volumes etc. In total 
12 clinical studies were used for PV of the model (Table S1). Figs. 4, 5, 6 and 7 show the time-dependent 
[BS] in the different ADAM compartments, duodenum, jejunum I-II, ileum I & IV as well as colon re-
spectively, according to the region of the GI tract where samples collected in each study; the individual 
outputs of the ADBSM for all ADAM compartments for each in vivo study can be found in the supple-
mentary material.  
In Fig. 4A the simulated data were plotted against those reported by Yao  et al 2002. The ADBSM was 
able to capture the range of the individual [BS] profiles with 95% confidence interval. The mean maxi-
mum [BS] of the observed and simulated data was 16 ±14 mM and 13 ±14 mM, respectively, within the 
time period of the in vivo study; 15 min before a meal and 120 min after. Figs. 4A(a’ – d’) show the 
simulated individual profiles selected from the pool, with the best matching to the observed individual 
profiles. Unlike to the maximum [BS], where no significant differences were found between observed 
and simulated profiles (p=0.1, t-test), the values of the [BS] after ~5h were higher in observed data without 
showing further decline; see especially Individual 1 (Fig. 4Aa’)  and 2 and (Fig.4Ab’). If it’s assumed that 
these steady state concentrations are related to the fasted [BS] period for those individuals, perhaps the 
main reason for higher fasted [BS] in some individuals, might be the baseline fluid volumes differences 
between the virtual populations and the healthy volunteers.  
 
 
Fig.4.Time-dependent duodenal [BS] (BS Conc. mM) of ADBSM in duodenum overlaid with in vivo 
observations. The simulation was performed in different states according to the protocol of the clinical 
study: A) fed, Yao et al 2002; B) fed, Fields & Duthue 1965; C) fed, Riethorst et al 2016; D) fasted starting 
@4h followed by fed starting @10h, Kalantzi et al 2006; E) fed, Herenll et al 1990; F) fasted starting 
@4h followed by fed starting @9h, Clarysse et al 2009; (for details see supplementary material). 
 
 
Figs. 4B-E show PV of the model for the various studies which provided only the average [BS] vs time 
information. In these studies the average profile was within the predicted range of 5%-95% confident 
intervals. In fig.4B the maximum [BS] was 7.7 mM at 4.5h and 9.8mM at 4.9h for observed and simulated 
data, respectively (p=0.24). In observed data, fasted [BS] values were restored 1.5h from meal ingestion 
without further change after 2h. In the simulated profiles there was a deeper decrease in [BS] whereas 
steady state fasted [BS] values were restored 7h after a meal reaching similar values with the observed 
data. However the duration of the study is not long enough to know the evolution of [BS]. In fig.4C the 
fasting values of [BS], i.e. before meal (2.5-3.8 h), were 4.7 ±1.05 mM and 5.13 ±3.9 mM for observed 
and predicted data (p=0.12), respectively. In the fed period, i.e. 4.3 – 5.66 h, the [BS] values were 12.6 
±2.2 mM and 7.3 ±7.9 mM for observed and predicted data (p=0.001, t-test), respectively. So, there is a 
statistical significant difference in the fed state between observed and simulated values. In the simulated 
profile the [BS] declines faster than the observed values although the latter show still elevated [BS]. Ri-
ethorst et al noted that the [BS] were not restored to fasted values after 90 min of sampling following a 
meal. In addition, the observed [BS] showed oscillations, i.e. repeated peaks (see SFig.9) in the fed state. 
The mean simulated profile cannot explain adequately these in vivo observations. However, it should be 
mentioned that the model can capture the large variability of the observed data (see SFig. 9A) for both 
fasted and fed state within the physiological range. Only one virtual individual showed in fed state very 
high [BS] values (~100 mM) which is comparable to the highest value of 86.4 mM reported by Riethorst 
et al. In addition, in simulated profiles there is sharp increase in [BS], almost instantaneously upon meal 
ingestion. This is because, based on the model design, the GB responds immediately to a meal. However, 
it has been shown that there is a lag time between meal ingestion and GB emptying linked to the phase of 
IMMCc at which meal was given.58 However, there is only one study showing this and to the best of the 
current authors knowledge there is no other study investigating this phenomenon. It seems unlikely, alt-
hough motility was not recorded in the Riethorst et al study, that in all subjects the meal was given at the 
same IMMCc phase something which could explain the delayed response of the GB and hence a shift to 
the maximum peak upon GB contraction. Although, there is no information for the first 30 minutes in the 
Riethorst et al study, it seems that this is the only study where duodenal [BS] are so high. Most of the 
studies (Figs. A, D,  E and F) used for PV showed sharp increase and decrease of [BS] following the 
simulated profiles. This can be attributed to differences in the sampling time intervals and sample volume 
and hence how extensively the EHC has been interrupted, population differences in biliary secretions, 
fluid volumes,59 GI tract motility and so on. With regard to the multiple peaks in the observed profiles, 
SFig. 9B shows three characteristic simulated profiles with one close to the observed [BS] duodenal pro-
file. According to the selected virtual profiles, the subjects with the elevated multiple peaks should have 
GB kinetics which combine a deep decrease in GB volume upon meal ingestion followed by a more than 
25% reduction of the maximum anatomical volume in the first fasting emptying phase appearing once the 
prolonged refilling phase in the fed state has been completed (SFig.9C, virtual individual162-Trial1). 
These GB kinetics lead to no significant accumulation of BS in the GB (SFig.9D). In addition, the subjects 
are expected to have relatively low duodenal fluid volumes (SFig.9E) combined with low fluid transit 
times (see supplementary materials), resulting in elevated duodenal [BS]. However, these conditions are 
for an average subject whereas individual profiles, if available, may tell a different story.  
Prolonged measurements of duodenal [BS] as in the Clarysse et al 2009 study (Fig.4F (a’-d’)) showed 
multiple peaks appearing in [BS] several hours after a meal. There may be several reasons for these sec-
ondary peaks. It may be due to the GB fasting emptying-filling cycle which may appear sooner than the 
simulated profile. However, this cannot be absolutely true because it takes several hours for the GB to 
enter its fasting profile as a prolonged refilling phase take places after the strong GB contraction of due 
to meal ingestion.60 This can be also seen from the mean simulated profile (Fig. 4F) where a rise of the 
[BS] and the following peaks were observed several hours after a meal. This deep drop in [BS] after the 
high peak (between ~5 – 7.4h) is related mainly to GB kinetics where the GB enters the refilling phase, 
 
hepatic secretions are lower (i.e. back to fasting secretion rates) and to the dilution of the duodenal con-
tents due to elevated fluid volumes. Another possible reason that is not known to have been explored 
and/or utilized in PBPK modelling is the “to and fro” fluid motion across intestine which might cause 
these secondary peaks.61 A further possibility gastric emptying which is known to occur as a sequence of 
spurts.62 However, the remaining food in the stomach might not be sufficient to trigger repeated GB emp-
tying and/or elevated hepatic secretions. This is because in vivo studies have shown no evidence of high 
biliary secretions in duodenal aspirates, expect from the initial high peak in [BS] due to GB emptying, 
after continuous or intermittent feeding with the [BS] equal to the fasted values on average.54 This might 
related to the feedback mechanism controlling GB contractions.63 The model doesn’t allow the GB to 
contract before five gastric emptying half-life (~4h) have been completed. This is also in accordance with 
the available experimental information where the shortest time intervals between meals is 4h showing 
repeating GB contractions without the GB reaching its maximum volume and then entering to the fasting 
filling-emptying cycles. It should be also pointed out that the model was able to capture the drop and rise 
of [BS] in fasting periods when only water is provided; see Fig.4F and individual profiles Fig4F(a’-d’) 
between 4.5 – 6.5h.  
 Fig.5.Time-dependent Bile Salt outputs (BS Conc. 
mM) of ADBSM in Jejunum I-II overlaid with in 
vivo observations. The simulation was performed at 
different states according to the protocol of the clini-
cal study: A) fed; B) fasted; C) fasted; D) fed (see 
supplementary material). 
Fig. 5 shows the time-dependent [BS] in the proxi-
mal jejunum (in the ADAM model this corresponds 
to jejunum I, Fig.5 A –C) and distal jejunum (ADAM 
model jejunum II, Fig.5 D). In the Fields & Duthue 
study, sampling was conducted in different segments 
of the small intestine. The model picks up the range 
in most of the observed data, including variability 
(see Fig. 5A, Fig. 5B and Fig. 5C). However, in the 
case of jejunum II (Fig. 5D), the maximum [BS] ap-
peared sooner compared to the simulated profile. 
Looking at the simulated individual profiles this 
could be because of differences in the transit times 
used in the model and those of the participants in the 
Fields & Duthue study. However, this information is 
not directly available from the in vivo study, but per-
haps the transit times are more rapid compared to the 
values in Simcyp® library. Thus, the model doesn’t 
capture the Tmax for this study, but this could be im-
proved by adjusting the transit time rate constant. In 
this simulation only 3 virtual individuals were found 
to have sufficiently rapid transit times after a meal. 
The majority of the simulated profiles had Tmax > 
0.5h with mean=1.2 ±1.5h after a meal. This reflects 
the physiology of the selected virtual population (Healthy Volunteers). The fact that the model can capture 
the observed data for most of the studies, shows that the built-in distribution of the transit times reflects 
actual population distribution here. The physiological parameters provided by Simcyp®, in this case fluid 
transit times, is based on an extensive meta-analysis covering separately different populations and differ-
ent moieties, i.e. fluids, tablets, fine particles and so on. So, in this work the fluid transit times reflect BS 
 
 
transit times. However, the transit times used in publications, where a bile salt model was built to capture 
the time-dependent concentration profiles of BS, have been derived from mixed populations64 whereas in 
other models covering different aspects, e.g. bile salt metabolism, the same authors may have used differ-
ent intestinal transit times.65 Looking into the literature, it was found that this is the case for most of the 
developed, reported EHC models66 while in some cases calibration of the model with respect to intestinal 
fluid transit times has been performed based on values for non-disintegrating tablets67 which are not ex-
pected to match fluid transit.68 With regards to the baseline [BS], the lowest observed [BS] was 0.83 mM 
in Moreno et al (2006) compared to the predicted lowest [BS] at steady state of 1.2 mM (fig. 5B). Based 
on model structure, [BS] cannot go below the baseline concentration assigned to an individual. This can 
be improved by either increasing %CV or decreasing the mean baseline [BS] or increase the passive ab-
sorption rate (Pappcoef, Table 3). In the first case, the range of the confidence intervals will be wider, 
allowing the observed data to be within this range, whereas in the second and third cases the simulated 
curves would shift toward lower [BS]. In any case any change should be justified from meta-analysis of 
the available data in the public domain. Furthermore, any change to the jejunum I segment would have a 
knock-on effect on the time-dependent [BS] profile in remaining aboral segments. Thus further adjustment 
should be done to predict [BS] from other studies. However, the purpose of this work was to evaluate the 
predictivity of the model, without adjusting it according to the observed values of individual studies.  
Fig. 6 shows the time-dependent [BS] in Ileum I (fig.6A) and Ileum IV (fig.6B-C). In the case of Ileum 
I, the increase in [BS] occurs at the same rate for the simulated and observed data and this extends to high 
[BS] for the simulated profile. Repeating the procedure performed for the Riethorst et al 2016 study, it 
was found that a virtual individual, matching the mean observed profile from Fields & Duthue 1965 study, 
should have Jmax=2.83 and Km=0.67 (active absorption kinetics) which is higher than the mean values, 
Jmax=2.47 Km=0.58, as well as lower fluid volumes compared to the mean profile and shorter Tmax; 
mean=6.42h, selected virtual individual 4.8h (SF10.B). 
 
 
Fig.6. Mean time-dependent Bile Salt concentrations (BS Conc. mM) of ADBSM in Ileum I&IV over-
laid with in vivo observations. The simulation was performed at different states according to the protocol 
of the clinical study: A) fed; B) fed; C) fasted (see supplementary material). 
 
Both absorption kinetics and transit times are not easy to appropriately-mechanistically reproduce. There 
are limited perfusion studies in humans for bile salt absorption in different regions of the GI tract. Ab-
sorption is more complex when a mixture of bile salts is perfused compared to a single bile salt.23 Fur-
thermore, the available perfusion studies have been conducted for specific bile salts and hence the absorp-
tion kinetics in the current model are applied to a fraction of the total [BS], reflecting the fraction of that 
specific BS. 
However, the composition of bile salts is not the same between populations2 and not all the studies provide 
this information. With respect to the transit times (residence times), used in the ADAM model these are 
 
derived only from scintigraphy and/or MRI studies which give the total and not the regional (segmental) 
transit times in the small intestine. The regional transit values used in the ADAM model assume residence 
time is proportional to anatomical length – population variability in regional residence times is derived 
from population variability in these lengths. To the authors knowledge even where regional transit has 
been assessed for a particular GI tract region69 there is a lack of information on total small intestinal transit 
time in the same subjects. However, a priori it seems reasonable that slow or fast transit times can occur 
within the same and/or different regions, even of the same length due to different motility patterns, e.g. 
forward or backward propagating waves.61 In spite of these issues, the model can capture the mean values 
of [BS] as reported by Reppas et al 2015 (Fig.6B). It should be mentioned that the terminal ileum is a 
complicated region with distinctive motility with respect to the distal ileum, which regulates emptying 
into the colon. However, the model captures adequately the observed data with the mean simulated [BS] 
profile matching surprisingly closely the observed mean [BS] (Fig.6B), taking into account that the model 
was informed only with the meal time and the number of subjects.  
Fig.7 shows the mean simulated profile of [BS] in the colon. The observed mean [BS] is slightly lower 
(~0.11 mM) than the 5th percentile curve (0.125 mM). Diakidou et al 2009 aspirated contents of the 
ascending colon whereas in the ADAM model at the time of writing there is a single segment for the 
colon. Similar adjustments, as mentioned above in the Moreno et al 2006 study (Fig.5B), could be applied 
to the model.  
Specifically, higher passive absorption can be applied alongside higher fraction of bile salt available for 
absorption. However, colonic absorption is more complicated, as metabolism of the conjugated bile salts 
takes place by the microbiota and absorption kinetics of the unconjugated BS will in general differ from 
the conjugated forms. The current model uses absorption kinetics of unconjugated BS based on the avail-
able data24 but it does not account for luminal metabolism. Furthermore, the passive absorption coefficient 
is derived from a single bile acid, specifically chenodeoxycholate (CDCA). However, this parameter is 
expected to differ for each bile acid albeit such information is not available. Furthermore, the mean fluid 
volume in the colonic compartment was ~10 mL whereas Diakidou et al 2009 reported volumes of 22.3 
±7.7 mL. This is double the baseline fluid volumes in the ADAM model and higher volumes would bring 
[BS] down to the observed values. Indeed, changing the default values of the fluid volumes (mean=11.92 
mL, %CV=90), to mean=22.3 mL and %CV=34.5, the mean simulated [BS] is much closer to the ob-
served data (SF11B). 
Fig.7. Mean time-dependent Bile Salt concentrations (BS Conc. mM) of ADBSM in colon overlaid with 
in vivo observations. The simulation was performed at fasted state according to the protocol of the clinical 
study (see supplementary material). 
 
 
Fig. 8 shows the overall predictiveness of the model by taking the ratio of observed to predicted [BS] 
values. The ratios have been calculated from the mean of the all-time-dependent observed data divided 
by the predicted values within the same time period. All the ratios were within two fold with most of them 
(11/20) within 1.25 fold. 
 
Fig.8. Observed versus predicted [BStotal] ratio. The solid line represents the line of unity and the dotted 
lines the 2-fold error thresholds. 
 
CONCLUSIONS 
A population-based PBPK model was developed for the prediction of total bile salt disposition within 
the GI luminal fluids. The available studies for performance verification of the model provided only the 
meal time, the number of the subjects and their gender and age. The model was not adjusted or optimized 
to better simulate a specific study. The development of the model was based on current knowledge of 
human physiology and its predictivity was assessed using in vivo studies providing only luminal bile salt 
concentrations. The time variant luminal [BS] is a complex interplay of intestinal transit times, fluid vol-
umes, absorption, secretions and the time course of a low or high fat meal with or without water intake at 
different times. Also, the sampling technique and intensity of the sampling can interrupt the EHC of BS 
to various extents, resulting in alterations to luminal [BS], adding more complexity to accurate prediction 
of [BS] over time. However, it is essential to have deep knowledge of human physiology and the draw-
backs/limitations of the methods used to obtain these data. It is the intention of this work to further con-
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GBV, gallbladder volume; mGBV, maximum gallbladder volume; IMMC, intermediate migrating motor 
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(i.e. steady state);  MRI, magnetic resonance imaging;  Pappcoef, apparent permeability coefficient 
(mmol/h/mM); Jmax, maximum rate of bile acid uptake (mmol/h); Km, Michaelis-Menten constant 
(mmol); PV, performance verification; emptying rate constant 𝑘𝑘𝑚𝑚𝑚𝑚𝑒𝑒𝑚𝑚𝑓𝑓𝑒𝑒𝑑𝑑, emptying rate constant (h-1); 
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(mmol/h); Vi(t), time-dependent fluid volume in the fasted or fed state in the ith ADAM GI tract segment; 
BSm, bile salt mass (mmol) in each segment; 
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Table S1. Details of the clinical studies used for the Performance Verification of the ADBSM. 
* Midintestine section 150-190cm taken as distal jejunum according to divisions determined from 
ICRP; **different volumes of water were given at different time points before aspiration (see Reppas 
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SF1. ADBSM outputs using Clarysse et al 2009 fasting-fed protocol. Blue arrow indicates water 
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SF2. The image below shows the settings of the trial design in the simulator (Simcyp v18r2) based on 
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SF3. The image below shows the settings of the trial design in the simulator (Simcyp v18r2) based on 
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SF4. The image below shows the settings of the trial design in the simulator (Simcyp v18r2) based on 













































































































































































































































































SF5. The image below shows the settings of the trial design in the simulator (Simcyp v18r2) based on 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SFig. 9. Riethorst et al 2016 (continued) 
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